| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P2093 | author name string | Yi Huang | |
| George Wu | |||
| Yong Wan | |||
| Nancy E Davidson | |||
| Zhuan Zhou | |||
| Amit Shetty | |||
| Joe X Qiao | |||
| P2860 | cites work | Cytotoxic bistetrahydrofuran annonaceous acetogenins from the seeds of Annona squamosa | Q82096722 |
| Two new cytotoxic acetogenins from Annona squamosa | Q83756582 | ||
| Extranuclear expression of hormone receptors in primary breast cancer | Q83946426 | ||
| Global cancer statistics | Q22241238 | ||
| Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases | Q24292875 | ||
| Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation | Q24302554 | ||
| Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1) | Q24306057 | ||
| Regulation of p53 activity through lysine methylation | Q24311514 | ||
| BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen | Q24316813 | ||
| Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain | Q24316893 | ||
| Regulation of estrogen rapid signaling through arginine methylation by PRMT1 | Q24317316 | ||
| Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5 | Q24317645 | ||
| Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 | Q24324556 | ||
| Gene-specific modulation of TAF10 function by SET9-mediated methylation | Q24337399 | ||
| c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements | Q24337860 | ||
| Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I) | Q24528261 | ||
| Differential oestrogen receptor binding is associated with clinical outcome in breast cancer | Q24595511 | ||
| Hormone action in the mammary gland | Q24604954 | ||
| Pioneer transcription factors: establishing competence for gene expression | Q24625373 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome | Q24657877 | ||
| Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation | Q24672514 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study | Q25257794 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Structural insights into the mode of action of a pure antiestrogen | Q27630646 | ||
| Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase | Q27650581 | ||
| The architecture of respiratory complex I | Q27661963 | ||
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
| The language of covalent histone modifications | Q27860931 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Estrogen receptor null mice: what have we learned and where will they lead us? | Q28137633 | ||
| Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor | Q28142019 | ||
| The role of integrin-linked kinase (ILK) in cancer progression | Q28190174 | ||
| Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha | Q28210188 | ||
| Molecular determinants for the tissue specificity of SERMs | Q28211516 | ||
| A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm | Q28217197 | ||
| The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
| AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer | Q28245902 | ||
| Extranuclear coactivator signaling confers insensitivity to tamoxifen | Q28246263 | ||
| The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype | Q28247404 | ||
| The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling | Q28252084 | ||
| Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity | Q28257118 | ||
| Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 | Q28260929 | ||
| Differential PIAS3 expression in human malignancy | Q28261248 | ||
| Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints | Q28266170 | ||
| Functional implications of altered subcellular localization of PELP1 in breast cancer cells | Q28270490 | ||
| The regulation of E2F by pRB-family proteins | Q28278789 | ||
| Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells | Q28282169 | ||
| Molecular definition of breast tumor heterogeneity | Q28292256 | ||
| Estrogen carcinogenesis in breast cancer | Q28292500 | ||
| Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences | Q28299630 | ||
| SET domain proteins modulate chromatin domains in eu- and heterochromatin. | Q34458687 | ||
| The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene | Q34462232 | ||
| Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin | Q34465352 | ||
| KLF4, p21 and context-dependent opposing forces in cancer | Q34478868 | ||
| Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland | Q34479251 | ||
| The Actin-binding Protein, Actinin Alpha 4 (ACTN4), Is a Nuclear Receptor Coactivator that Promotes Proliferation of MCF-7 Breast Cancer Cells | Q34503108 | ||
| Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer | Q34549350 | ||
| Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. | Q34557743 | ||
| Historical perspective on hormonal therapy of advanced breast cancer | Q34575679 | ||
| Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action | Q34581963 | ||
| Regulation of Krüppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-beta signaling | Q34606049 | ||
| The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells | Q34609956 | ||
| Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP. | Q34617201 | ||
| Nuclear receptor coregulators and human disease | Q34645711 | ||
| Regulation of progesterone receptor signaling by BRCA1 in mammary cancer | Q34652156 | ||
| Selective estrogen-receptor modulators and antihormonal resistance in breast cancer | Q34692670 | ||
| MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells | Q34754561 | ||
| Breast cancer stem cells revealed | Q34913482 | ||
| Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis | Q34992779 | ||
| KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis | Q35023925 | ||
| Nongenomic actions of steroid hormones | Q35038285 | ||
| A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer | Q35052559 | ||
| The NuRD complex: linking histone modification to nucleosome remodeling. | Q35070017 | ||
| Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice | Q35085031 | ||
| Cyclin D1, EMS1 and 11q13 amplification in breast cancer | Q35130688 | ||
| Biological evaluation of new mimetics of annonaceous acetogenins: alteration of right scaffold by click linkage with aromatic functionalities. | Q35135905 | ||
| Aromatase inhibitors in breast cancer | Q35152297 | ||
| Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials | Q35186747 | ||
| Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy | Q35198394 | ||
| Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice | Q35417300 | ||
| Histone lysine methylation: a signature for chromatin function | Q35571556 | ||
| Steroid receptors and proliferation in the human breast. | Q35605004 | ||
| Estrogen receptor corepressors -- a role in human breast cancer? | Q35624506 | ||
| Dual role of SnoN in mammalian tumorigenesis | Q35641680 | ||
| Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action | Q33986168 | ||
| Mammary gland development and tumorigenesis in estrogen receptor knockout mice | Q33997388 | ||
| Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family | Q34013708 | ||
| The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis | Q34024643 | ||
| Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. | Q34108153 | ||
| The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. | Q34128767 | ||
| Rapid actions of plasma membrane estrogen receptors | Q34214352 | ||
| Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia | Q34338550 | ||
| Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice | Q34342812 | ||
| Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling | Q34411645 | ||
| Antitumor activity of annonaceous acetogenins in HepS and S180 xenografts bearing mice | Q39374473 | ||
| ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. | Q39401307 | ||
| Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. | Q39542346 | ||
| Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks | Q39626579 | ||
| Effects of estrogen on the proportion of stem cells in the breast. | Q39652970 | ||
| Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1. | Q39754043 | ||
| Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells | Q39852846 | ||
| Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer | Q39862906 | ||
| CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions. | Q39865315 | ||
| Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells | Q39868655 | ||
| S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation | Q39900962 | ||
| Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements | Q39947046 | ||
| Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists | Q39960786 | ||
| Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals | Q39973430 | ||
| Repression of transcriptional activity of estrogen receptor alpha by a Cullin3/SPOP ubiquitin E3 ligase complex | Q39991661 | ||
| DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression | Q40026501 | ||
| Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response. | Q40041160 | ||
| Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer | Q40093802 | ||
| Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. | Q40107103 | ||
| Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents | Q40124566 | ||
| An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration. | Q40207973 | ||
| Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. | Q40230408 | ||
| Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes | Q40266897 | ||
| MUC1 oncoprotein stabilizes and activates estrogen receptor alpha | Q40326798 | ||
| E6AP and calmodulin reciprocally regulate estrogen receptor stability. | Q40346484 | ||
| Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells | Q40424228 | ||
| Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. | Q40428340 | ||
| Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites. | Q40468127 | ||
| Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor | Q40493369 | ||
| Nine new cytotoxic monotetrahydrofuranic Annonaceous acetogenins from Annona montana. | Q40503068 | ||
| Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements | Q40515616 | ||
| Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer | Q40544950 | ||
| Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7. | Q40550400 | ||
| Repression of endogenous Smad7 by Ski. | Q40558828 | ||
| Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer | Q40564116 | ||
| Cell cycle control by steroid hormones | Q40588075 | ||
| Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo | Q40599656 | ||
| The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction | Q40763954 | ||
| Estrogen receptor beta acts as a dominant regulator of estrogen signaling | Q40847288 | ||
| Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. | Q41104168 | ||
| Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. | Q41115396 | ||
| Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen | Q41222398 | ||
| Think globally, act locally: the making of a mouse mammary gland. | Q41705141 | ||
| Overexpressions of c-fos/jun mRNA and their oncoproteins (Fos/Jun) in the mouse uterus treated with three natural estrogens | Q42274796 | ||
| Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells | Q42470095 | ||
| CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha | Q42481557 | ||
| Steroid hormone receptor status of mouse mammary stem cells | Q42498451 | ||
| Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells | Q42513860 | ||
| Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu | Q42807740 | ||
| Control of mammary stem cell function by steroid hormone signalling. | Q43103606 | ||
| Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain | Q43807134 | ||
| Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells | Q44033734 | ||
| Smad4 as a transcription corepressor for estrogen receptor alpha | Q44308474 | ||
| Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen | Q44396175 | ||
| Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis | Q44958626 | ||
| Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element | Q35644045 | ||
| Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease | Q35679460 | ||
| Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase | Q35749504 | ||
| A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer | Q35750639 | ||
| Estrogen receptor-positive proliferating cells in the normal and precancerous breast. | Q35787982 | ||
| Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer | Q35794355 | ||
| Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion | Q35810732 | ||
| Breast cancer, stem/progenitor cells and the estrogen receptor | Q35820494 | ||
| Transcriptional activation by nuclear receptors | Q35830313 | ||
| Post-translational modifications of nuclear receptors and human disease | Q35842790 | ||
| Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation | Q35849279 | ||
| Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt | Q35918889 | ||
| Human breast cell proliferation and its relationship to steroid receptor expression. | Q35924753 | ||
| Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes | Q35974510 | ||
| Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice | Q35990241 | ||
| Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes | Q36032594 | ||
| Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer | Q36035275 | ||
| Ligand control of coregulator recruitment to nuclear receptors | Q36041022 | ||
| PES1 promotes breast cancer by differentially regulating ERα and ERβ. | Q36129096 | ||
| Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. | Q36236632 | ||
| Role of SUMOylation in full antiestrogenicity | Q36277244 | ||
| A repressive role for prohibitin in estrogen signaling. | Q36447412 | ||
| Reversible inhibition of mammary gland growth by transforming growth factor-beta | Q36459241 | ||
| The expanding cosmos of nuclear receptor coactivators | Q36469825 | ||
| Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity | Q36514584 | ||
| Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1. | Q36540639 | ||
| Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches | Q36568023 | ||
| Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution | Q36569390 | ||
| The role of the IGF system in cancer growth and metastasis: overview and recent insights | Q36576678 | ||
| Derailed estrogen signaling and breast cancer: an authentic couple. | Q36589361 | ||
| Epigenetics and the estrogen receptor | Q36721730 | ||
| SnoN oncoprotein enhances estrogen receptor-α transcriptional activity | Q36730663 | ||
| SUMO and estrogen receptors in breast cancer | Q36766502 | ||
| Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor | Q28304891 | ||
| Comparative analyses of mechanistic differences among antiestrogens | Q28377133 | ||
| Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes | Q28504877 | ||
| Induction of mammary gland development in estrogen receptor-alpha knockout mice | Q28589902 | ||
| Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us? | Q29030220 | ||
| An oestrogen-receptor-α-bound human chromatin interactome | Q29541719 | ||
| Generation of a functional mammary gland from a single stem cell | Q29616496 | ||
| Purification and unique properties of mammary epithelial stem cells | Q29616497 | ||
| Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase | Q29617567 | ||
| Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group | Q29619251 | ||
| Cells of origin in cancer | Q29619557 | ||
| Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties | Q29636244 | ||
| Estrogen Stimulation of Cell Migration Involves Multiple Signaling Pathway Interactions | Q30429931 | ||
| The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane | Q30432909 | ||
| Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions. | Q30439093 | ||
| Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase | Q30439814 | ||
| Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. | Q30727226 | ||
| A putative human breast stem cell population is enriched for steroid receptor-positive cells | Q33210333 | ||
| Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway | Q33227192 | ||
| Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition | Q33411645 | ||
| Steroid hormone receptors in breast cancer management | Q33539154 | ||
| Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol | Q33564705 | ||
| BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha | Q33576505 | ||
| Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells. | Q33642075 | ||
| Regulation of aromatase induction by nuclear receptor coregulator PELP1 | Q33678686 | ||
| HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb | Q33702169 | ||
| The Molecular Pharmacology of SERMs | Q33730355 | ||
| Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization | Q33777797 | ||
| Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling | Q33780210 | ||
| Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation | Q33825125 | ||
| The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors | Q33881484 | ||
| Increase of GKLF messenger RNA and protein expression during progression of breast cancer | Q33927101 | ||
| Human breast development | Q33930666 | ||
| Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity | Q33940612 | ||
| Regulation of the functional interaction between cyclin D1 and the estrogen receptor | Q33966444 | ||
| 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin. | Q33983217 | ||
| The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression | Q36898979 | ||
| Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells | Q36935732 | ||
| Minireview: nuclear receptors and breast cancer | Q36971797 | ||
| Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. | Q37083658 | ||
| Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland | Q37094546 | ||
| Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen | Q37101433 | ||
| Estrogen receptors alpha and beta in the rodent mammary gland | Q37152373 | ||
| Targeting Src in breast cancer | Q37167029 | ||
| Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair | Q37262148 | ||
| Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? | Q37277121 | ||
| Regulating the stability of TGFbeta receptors and Smads | Q37333694 | ||
| Proliferation of breast cancer cells: regulation, mediators, targets for therapy | Q37347045 | ||
| Ski and SnoN, potent negative regulators of TGF-beta signaling | Q37359949 | ||
| Resistance to endocrine therapy: are breast cancer stem cells the culprits? | Q37404590 | ||
| Coactivator AIB1 links estrogen receptor transcriptional activity and stability | Q37415295 | ||
| The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer | Q37428211 | ||
| Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer | Q37454936 | ||
| The silent estrogen receptor--can we make it speak? | Q37468213 | ||
| Membrane oestrogen receptor alpha signalling to cell functions | Q37581224 | ||
| Genomic analyses of hormone signaling and gene regulation | Q37690710 | ||
| Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis | Q37695618 | ||
| Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates | Q37726327 | ||
| Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer | Q37805183 | ||
| Clinical significance of estrogen receptor phosphorylation | Q37819658 | ||
| Emerging significance of estrogen cancer coregulator signaling in breast cancer. | Q37983997 | ||
| Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling | Q38000121 | ||
| Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling | Q38356127 | ||
| Metastatic behavior of breast cancer subtypes | Q38416421 | ||
| Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma | Q38479914 | ||
| Six cytotoxic annonaceous acetogenins from Annona squamosa seeds | Q38942593 | ||
| Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis. | Q39125264 | ||
| Structure-activity relationships of hybrid annonaceous acetogenins: powerful growth inhibitory effects of their connecting groups between heterocycle and hydrophobic carbon chain bearing THF ring on human cancer cell lines | Q39166175 | ||
| Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. | Q39347752 | ||
| Novel cytotoxic annonaceous acetogenins from Annona muricata | Q74266928 | ||
| Essential structural factors of annonaceous acetogenins as potent inhibitors of mitochondrial complex I | Q77120344 | ||
| Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse | Q78480627 | ||
| Cyclins and breast cancer | Q79922062 | ||
| Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors | Q80695171 | ||
| Estrogen receptor activation function 1 works by binding p160 coactivator proteins | Q46064993 | ||
| Low SAFB levels are associated with worse outcome in breast cancer patients | Q46167250 | ||
| The history and mechanism of action of fulvestrant | Q46467888 | ||
| Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory | Q46589624 | ||
| Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor | Q46728761 | ||
| The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer | Q46914764 | ||
| Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha | Q46928900 | ||
| A potent specific pure antiestrogen with clinical potential | Q46965638 | ||
| Activin and estrogen crosstalk regulates transcription in human breast cancer cells | Q46968617 | ||
| Alternate splicing produces a novel cyclin D1 transcript | Q48070740 | ||
| Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state | Q50668328 | ||
| Two separate mechanisms for ligand-independent activation of the estrogen receptor. | Q52194366 | ||
| Dissociation between steroid receptor expression and cell proliferation in the human breast. | Q52528046 | ||
| Definition of crucial structural factors of acetogenins, potent inhibitors of mitochondrial complex I. | Q52584475 | ||
| Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. | Q53321709 | ||
| Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. | Q53399983 | ||
| Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen. | Q53540759 | ||
| Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers. | Q54298193 | ||
| Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy. | Q54400297 | ||
| Turning Off Estrogen Receptor β-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis. | Q55614784 | ||
| High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer | Q58423623 | ||
| Distinct stem cells contribute to mammary gland development and maintenance | Q59067141 | ||
| Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expressionin Vitroandin Vivo | Q62267728 | ||
| Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status | Q62267748 | ||
| Aromatization of androgens by muscle and adipose tissue in vivo | Q67451927 | ||
| Study on the estrogen production in parenchymatous cells of epithelial ovarian tumor | Q68049255 | ||
| Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity | Q68644618 | ||
| Novel steroidal pure antiestrogens | Q69798290 | ||
| Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells | Q72386166 | ||
| Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells | Q72524963 | ||
| Inducible regulatory elements in the human cyclin D1 promoter | Q72530064 | ||
| Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein | Q73034011 | ||
| Additional bioactive annonaceous acetogenins from Asimina triloba (Annonaceae) | Q73253742 | ||
| Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast | Q73653641 | ||
| Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells | Q73702915 | ||
| Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas | Q73865005 | ||
| Estrogen receptor expression in benign breast epithelium and breast cancer risk | Q74038716 | ||
| A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions | Q74181062 | ||
| Rapid uptake and binding of estradiol-17beta-6-(O-carboxymethyl)oxime:125I-labeled BSA by female rat liver | Q74220615 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| carcinogenesis | Q1637543 | ||
| P304 | page(s) | 1549 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy | |
| P478 | volume | 71 |
| Q36175376 | A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models |
| Q39193601 | An interspecies conserved motif of the mouse immune system-released activating agent (ISRAA) induces proliferative effects on human cells |
| Q125445438 | Analysis of Essential Oils Components from Aromatic Plants Using Headspace Repellent Method against Aedes aegypti Mosquitoes |
| Q37705861 | Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells |
| Q92769181 | Basic helix-loop-helix transcription factor Twist1 is a novel regulator of anterior gradient protein 2 homolog (AGR2) in breast cancer |
| Q91737827 | Cytotoxicity Of Chalcone Of Eugenia aquea Burm F. Leaves Against T47D Breast Cancer Cell Lines And Its Prediction As An Estrogen Receptor Antagonist Based On Pharmacophore-Molecular Dynamics Simulation |
| Q90260424 | Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells |
| Q33598114 | Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy |
| Q38988553 | GPER mediates activation of HIF1α/VEGF signaling by estrogens |
| Q36276533 | How interacting pathways are regulated by miRNAs in breast cancer subtypes |
| Q112283232 | Identification of Diagnostic Markers for Breast Cancer Based on Differential Gene Expression and Pathway Network |
| Q35116300 | Krüppel-like factors are effectors of nuclear receptor signaling |
| Q58594877 | Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1 |
| Q104142699 | Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer |
| Q92595163 | Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer |
| Q50467647 | SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy |
| Q89411150 | The effect of TGF-β signaling on regulating proliferation of uterine leiomyoma cell via ERα signaling activated by bisphenol A, octylphenol and nonylphenol in vitro |
| Q42701067 | Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro |
| Q51175818 | Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer. |
Search more.